Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 78 | 3 | 2 | 1 | €265.00 | €331.61 | 25.137% |
| Eli Lilly Corp. | 72 | 2 | 7 | 1 | €793.30 | €991.05 | 24.928% |
| Gilead Sciences Inc | 55 | 0 | 3 | 0 | €117.38 | €124.75 | 6.278% |
| Intuitive Surgical Inc | 54 | 2 | 3 | 0 | €387.70 | €523.55 | 35.040% |
| Vertex Pharmaceuticals Inc. | 47 | 0 | 2 | 0 | €373.25 | €461.98 | 23.771% |
| HCA Holdings Inc. | 45 | 0 | 0 | 0 | €420.00 | €448.99 | 6.902% |
| Regeneron Pharmaceuticals Inc. | 45 | 1 | 3 | 0 | €628.70 | €707.12 | 12.473% |
| Dexcom Inc. | 43 | 1 | 1 | 0 | €53.60 | €77.13 | 43.899% |
| Johnson & Johnson | 41 | 1 | 7 | 0 | €201.35 | €215.09 | 6.825% |
| Medtronic plc | 38 | 1 | 5 | 0 | €74.50 | €95.74 | 28.506% |
| Cigna Corp. | 37 | 0 | 0 | 0 | €231.40 | €311.96 | 34.814% |
| Thermo Fisher Scientific Inc. | 35 | 0 | 1 | 0 | €432.70 | €504.64 | 16.626% |
| AbbVie Inc. | 33 | 0 | 3 | 0 | €173.60 | €208.89 | 20.327% |
| Edwards Lifesciences Corp. | 32 | 0 | 2 | 0 | €65.90 | €80.91 | 22.779% |
| Amgen Inc. | 34 | 3 | 1 | 0 | €296.30 | €305.71 | 3.177% |
| Biogen Inc. | 29 | 0 | 4 | 0 | €148.80 | €181.48 | 21.964% |
| BioMarin Pharmaceutical Inc. | 28 | 0 | 1 | 0 | €46.30 | €80.63 | 74.154% |
| Agilent Technologies Inc. | 27 | 0 | 0 | 0 | €99.90 | €139.61 | 39.746% |
| Stryker Corp. | 23 | 0 | 2 | 0 | €295.00 | €353.50 | 19.829% |
| Elanco Animal Health Inc. | 23 | 0 | 0 | 0 | €19.39 | €23.60 | 21.709% |
| Exact Sciences | 22 | 0 | 0 | 0 | €90.74 | - | - |
| Teva Pharmaceutical Industries Ltd ADR | 22 | 0 | 1 | 0 | €26.00 | €31.83 | 22.426% |
| Align Technology | 21 | 0 | 1 | 0 | €146.20 | €175.92 | 20.328% |
| Resmed Inc. | 20 | 0 | 2 | 0 | €195.85 | €256.90 | 31.172% |
| Merck & Co. Inc. | 17 | 0 | 2 | 0 | €101.96 | €115.68 | 13.458% |